VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: --

Managing Director: Kiran Mazumdar Shaw

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 12,334.00 Cr

Revenue (TTM): R 1,938.50 Cr

Earnings (TTM): R 392.00 Cr

Cash: R 1,152.90 Cr

Total Debt: R 813.30 Cr

Promoters' ownership: 70.70%

Liquidity: High

52 Week range: R 280.25 - 369.00

Face value: R10.00

Shares outstanding: 40,00,00,000

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD-4.865.783.18
1 month-0.860.69-2.39
3 months-6.596.014.79
1 Year2.494.548.94
3 Years5.95-2.534.50
5 Years---1.987.56
10 Years--11.389.32
As on 24-Feb-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis